The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Toward a NOTCH1/FBXW7/RAS/PTEN –Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study
Open accessAbstract
Purpose: The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL) recently reported a significantly better outcome in T-cell acute lymphoblastic leukemia (T-ALL) harboring NOTCH1 and/or FBXW7 (N/F) mutations compared with unmutated T-ALL. Despite this, one third of patients with N/F-mutated T-ALL experienced relapse. Patients and Methods: In a series of 212 adult T-ALLs included in the multicenter randomized GRAALL-2003 and -2005 trials, we searched for additional N/K-RAS mutations and PTEN defects (mutations and gene deletion). Results: N/F mutations were identified in 143 (67%) of 212 patients, and lack of N/F mutation was confirmed to be associated with a poor prognosis. K-RAS, N-RAS, and PTEN mutations/deletions were identified in three (1.6%) of 191, 17 (8.9%) of 191, and 21 (12%) of 175 patients, respectively. The favorable prognostic significance of N/F mutations was restricted to patients without RAS/PTEN abnormalities. These observations led us to propose a new T-ALL oncogenetic classifier defining low-risk patients as those with N/F mutation but no RAS/PTEN mutation (97 of 189 patients; 51%) and all other patients (49%; including 13% with N/F and RAS/PTEN mutations) as high-risk patients. In multivariable analysis, this oncogenetic classifier remained the only significant prognostic covariate (event-free survival: hazard ratio [HR], 3.2; 95% CI, 1.9 to 5.15; P < .001; and overall survival: HR, 3.2; 95% CI, 1.9 to 5.6; P < .001). Conclusion: These data demonstrate that the presence of N/F mutations in the absence of RAS or PTEN abnormalities predicts good outcome in almost 50% of adult T-ALL. Conversely, the absence of N/F or presence of RAS/PTEN alterations identifies the remaining cohort of patients with poor prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
PTEN: The down side of PI 3-kinase signalling
Leslie, N. R., & Downes, C. P. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00234-0 · Cited by 415
Cited by
Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
Yang, Y., Gao, X., Zhang, M., Yan, S., Sun, C., Xiao, F., Huang, N., Yang, X., Zhao, K., Zhou, H., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx166 · Cited by 1,114
Hoelzer, D., Bassan, R., Dombret, H., Fielding, A., Ribera, J. M., & Buske, C. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw025 · Cited by 463
Self-citationBeldjord, K., Chevret, S., Asnafi, V., Huguet, F., Boulland, M.-L., Leguay, T., Thomas, X., Cayuela, J.-M., Grardel, N., Chalandon, Y., et al. (2014) · Blood · doi:10.1182/blood-2014-01-547695 · Cited by 330
Self-citationRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicine
Hunger, S. P., & Mullighan, C. G. (2015) · Blood · doi:10.1182/blood-2015-02-580043 · Cited by 292
Dhédin, N., Huynh, A., Maury, S., Tabrizi, R., Beldjord, K., Asnafi, V., Thomas, X., Chevallier, P., Nguyen, S., Coiteux, V., et al. (2015) · Blood · doi:10.1182/blood-2014-09-599894 · Cited by 270
Self-citationThe genomic basis of childhood T-lineage acute lymphoblastic leukaemia
Pölönen, P., Di Giacomo, D., Seffernick, A. E., Elsayed, A., Kimura, S., Benini, F., Montefiori, L. E., Wood, B. L., Xu, J., Chen, C., et al. (2024) · Nature · doi:10.1038/s41586-024-07807-0 · Cited by 173
PTEN in Regulating Hematopoiesis and Leukemogenesis
Wu, Y., Zhu, H., & Wu, H. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036244 · Cited by 22
Metadata
- Authors
- Trinquand, A., Tanguy-Schmidt, A., Ben Abdelali, R., Lambert, J., Beldjord, K., Lengliné, E., De Gunzburg, N., Payet-Bornet, D., Lhermitte, L., Mossafa, H., Lhéritier, V., Bond, J., Huguet, F., Buzyn, A., Leguay, T., Cahn, J.-Y., Thomas, X., Chalandon, Y., Delannoy, A., Bonmati, C., Maury, S., Nadel, B., Macintyre, E., Ifrah, N., Dombret, H., & Asnafi, V.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-12-01
- Volume
- 31
- Issue
- 34
- Pages
- 4333-4342
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2137042680
- Cited by
- 247
- References
- 3
- FWCI
- 18.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.